Published in
Dove Press, Therapeutics and Clinical Risk Management, (Volume 15), p. 861-867
DOI: 10.2147/tcrm.s207515
Links
Tools
SGLT2 inhibitors and the changing landscape for treatment of diabetes
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 